When was Celcuity founded?

Celcuity was founded in 2012 and raised its 1st funding round 2 years after it was founded.

Where is Celcuity located?

Celcuity is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota.

How many employees does Celcuity have?

As of Jun 30, 2026, the latest employee count at Celcuity is 245.

Is Celcuity a funded company?

Celcuity is a funded company, having raised a total of $15.4M across 8 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Mar 21, 2014.

When was the latest funding round of Celcuity?

Celcuity's latest funding was a $***** Post IPO round on Oct 18, 2023, with participation from 0 investor.

Where does Celcuity rank among its competitors?

Celcuity ranks 72nd amongst 3262 active competitors, of which 1117 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of Celcuity?

Celcuity's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Senti Bio. Among them, Immuneel secured the most recent funding round in June, 2026.

Celcuity - 2026 Company Profile, Team, Funding, Competitors & Financials

Celcuity is a public company based in Minneapolis (United States), founded in 2012 by Brian Sullivan. It operates as a Developer of targeted therapies for cancer patients. Celcuity has raised $15.4M in funding from Brightstone Venture Capital. The company has 3262 active competitors, including 1117 funded and 774 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Senti Bio.

Company Details

Developer of targeted therapies for cancer patients. Its platform CELx Pathway Profile analyzes disease-related metabolic pathways in ex vivo patient samples for drug response markers. Their flagship products have completed preclinical trials.

Website: www.celcuity.com/
Registered Address: Minneapolis, Minnesota

Key Metrics

Founded Year

2012

Location

Minneapolis, United States

Stage

Public

Total Funding

$15.4M in 8 rounds

Latest Funding Round

Post IPO, Oct 18, 2023, $*****

Investors

Brightstone Venture Capital & 6 more

Ranked

72^nd among 3262 active competitors

Employee Count

245 as on Jun 30, 2026

Similar Companies

Jazz Pharmaceuticals & 2974 more

Exit Details

Public

View Celcuity's full profile

Celcuity is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CELCUITY INC. CIN: 822863566 , United States, Active	Dec 26, 999	-	89 (As on Dec 31, 2024)	-
Celcuity Inc. CIN: 20198015675 , United States, Active	Dec 18, 2019	-	-	-

Celcuity got listed on Sep 20, 2017.

Click here to take a look at Celcuity's IPO in detail

Celcuity has raised a total funding of $15.4M over 8 rounds. Its first funding round was on Mar 21, 2014. Celcuity has 7 institutional investors.

Here is the list of recent funding rounds of Celcuity:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 18, 2023	5351024	Post IPO	9811267	2239331	3168110	8174631
May 27, 2022	5136588	Post IPO	3086937	4531419	6337130	Venrock & 4 more
Apr 08, 2021	9167129	Post IPO	8714878	5902625	2996004	9210367

Access funding benchmarks and valuations. Sign up today!

View details of Celcuity's funding rounds and investors

The founders of Celcuity is Brian Sullivan.

Here are the details of Celcuity's key team members:

Brian Sullivan: Co-Founder & CEO of Celcuity.
Contact Info: 1 email address

View details of Celcuity's Founder profiles and Board Members

Celcuity's employee count trend

Celcuity has 245 employees as of Jun 26. Here is Celcuity's employee count trend over the years:

Uncover Celcuity's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Celcuity include Jazz Pharmaceuticals, Sana Biotechnology and Senti Bio. Here is the list of Top 10 competitors of Celcuity, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Google Ventures, Baillie Gifford & 17 others	75/100
3rd	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, New Enterprise Associates ... & 30 others	72/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	72/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
6th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
7th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
8th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	71/100
9th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
10th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, Khosla Ventures & 23 others	71/100
72nd	Celcuity 2012, Minneapolis (United States), Public	Developer of targeted therapies for cancer patients	$15.4M	Venrock, Commodore Capital & 5 others	65/100